News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,412 Results
Type
Article (39418)
Company Profile (249)
Press Release (653745)
Section
Business (204064)
Career Advice (2006)
Deals (35412)
Drug Delivery (93)
Drug Development (80956)
Employer Resources (169)
FDA (16137)
Job Trends (14832)
News (344939)
Policy (32480)
Tag
Academia (2536)
Alliances (49336)
Alzheimer's disease (1316)
Approvals (16124)
Artificial intelligence (208)
Bankruptcy (357)
Best Places to Work (11637)
Biotechnology (177)
Breast cancer (230)
Cancer (1760)
Cardiovascular disease (132)
Career advice (1670)
CAR-T (127)
Cell therapy (366)
Clinical research (65324)
Collaboration (685)
Compensation (376)
COVID-19 (2568)
C-suite (171)
Data (1674)
Diabetes (218)
Diagnostics (6300)
Earnings (85633)
Employer resources (145)
Events (111109)
Executive appointments (583)
FDA (17072)
Funding (616)
Gene therapy (251)
GLP-1 (656)
Government (4362)
Healthcare (18785)
Infectious disease (2684)
Interviews (311)
IPO (16470)
Job creations (3628)
Job search strategy (1421)
Layoffs (440)
Legal (7890)
Lung cancer (258)
Manufacturing (241)
Medical device (13273)
Medtech (13278)
Mergers & acquisitions (19329)
Metabolic disorders (565)
Neuroscience (1731)
NextGen: Class of 2025 (6509)
Non-profit (4476)
Northern California (2162)
Obesity (311)
Opinion (196)
Patents (173)
People (56896)
Phase I (20342)
Phase II (28776)
Phase III (21423)
Pipeline (769)
Postmarket research (2562)
Preclinical (8585)
Radiopharmaceuticals (242)
Rare diseases (328)
Real estate (5897)
Regulatory (21957)
Research institute (2314)
Resumes & cover letters (349)
Southern California (1857)
Startups (3569)
United States (19071)
Vaccines (617)
Weight loss (212)
Date
Last 7 days (799)
Last 30 days (2577)
Last 365 days (34229)
2025 (5225)
2024 (35220)
2023 (40076)
2022 (51173)
2021 (55717)
2020 (54092)
2019 (46545)
2018 (35025)
2017 (32115)
2016 (31484)
2015 (37556)
2014 (31319)
2013 (26346)
2012 (28575)
2011 (29266)
2010 (27334)
Location
Africa (717)
Arizona (211)
Asia (37539)
Australia (6136)
California (4932)
Canada (1745)
China (407)
Colorado (225)
Connecticut (234)
Europe (80509)
Florida (727)
Georgia (171)
Illinois (481)
Indiana (268)
Japan (125)
Maryland (756)
Massachusetts (3755)
Michigan (200)
Minnesota (341)
New Jersey (1394)
New York (1415)
North Carolina (851)
Northern California (2162)
Ohio (174)
Pennsylvania (1127)
South America (1093)
Southern California (1857)
Texas (723)
Utah (152)
Washington State (474)
693,412 Results for "ibio inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled “Low Glycemic Sugar Composition.”
Impact Biomedical Inc. (IBIO), in which DSS Inc.(NYSE American: DSS) has a significant investment, is thrilled to announce a milestone in its innovative Laetose™ technology platform.
January 30, 2024
·
2 min read
iBio Accelerates Transformation to AI-Powered Biotech
BRYAN, Texas and SAN DIEGO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”) an AI-driven innovator of precision antibody immunotherapies, announces it is seeking to divest its contract development and manufacturing organization
November 10, 2022
·
7 min read
iBio to Participate in the H.C. Wainwright Global Investment Conference
BRYAN, Texas, May 18, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable, plant-based FastPharming® Manufacturing System,
November 10, 2022
·
1 min read
iBio Acquires RubrYc Therapeutics’ AI Drug Discovery Platform and Pipeline
SAN DIEGO and BRYAN, Texas, Sept. 21, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System
November 10, 2022
·
7 min read
iBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update
BRYAN, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the sustainable FastPharming® Manufacturing System,
November 10, 2022
·
15 min read
iBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
BRYAN, Texas and SAN DIEGO, Sept. 27, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a developer of next-generation biopharmaceuticals and pioneer of the
November 10, 2022
·
10 min read
Business
RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.
RubrYc Therapeutics, Inc. (“RubrYc”) and iBio, Inc. (“iBio”, NYSEA: IBIO) announced today the closing of RubrYc’s Series A2 Preferred Financing, and concomitant License and Collaboration Agreements directed towards the research, development, and commercialization of epitope-targeted antibody therapeutics.
August 25, 2021
·
4 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Press Releases
Moss Genomics Inc. Announces Leadership Changes
February 26, 2025
·
5 min read
Press Releases
Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
February 12, 2025
·
6 min read
1 of 69,342
Next
